ホーム 米国株 RARE Ultragenyx Pharmaceutical Inc. Common Stock トップ 業種一覧 リターンランキング ヒートマップ 指数の採用・除外 候補 上場廃止銘柄 米国ETF一覧 ファクターバックテスト 米国株 R ‹ R Ryder System, Inc. Common Stock RACE Ferrari N.V. Common Shares RAIL FreightCar America, Inc. Common Stock RAND Rand Capital Corporation Common Stock RANI Rani Therapeutics Holdings, Inc. Class A Common Stock RARE Ultragenyx Pharmaceutical Inc. Common Stock RAVE Rave Restaurant Group, Inc. Common Stock RAY Raytech Holding Limited Ordinary Shares RAYA Erayak Power Solution Group Inc. Class A Ordinary Shares RBA RB Global, Inc. Common Stock RBC RBC Bearings Incorporated Common Stock RBLX Roblox Corporation Class A Common Stock RBNE Robin Energy Ltd. Common Stock RBRK Rubrik, Inc. Class A Common Stock RCI Rogers Communication, Inc. Common Stock RCON Recon Technology, Ltd. Class A Ordinary Shares RCT RedCloud Holdings plc Ordinary Shares RDCM Radcom Ltd. Ordinary Shares RDDT Reddit, Inc. Class A Common Stock RDGT Ridgetech, Inc. Ordinary Shares RDHL Redhill Biopharma Ltd. American Depositary Shares RDI Reading International Inc Class A Common Stock RDNW RideNow Group, Inc. Class B Common Stock RDWR Radware Ltd. Ordinary Shares RDY Dr. Reddy's Laboratories Ltd Common Stock RDZN Roadzen, Inc. Ordinary Shares REBN Reborn Coffee, Inc. Common Stock RECT Rectitude Holdings Ltd Ordinary Shares REE REE Automotive Ltd. Class A Ordinary Shares REFR Research Frontiers Incorporated Common Stock REI Ring Energy, Inc. Common Stock REKR Rekor Systems, Inc. Common Stock RELX RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) RENT Rent the Runway, Inc. Class A Common Stock RENX RenX Enterprises Corp. Common Stock RERE ATRenew Inc. American Depositary Shares (every three of which representing two Class A ordinary shares) RETO ReTo Eco-Solutions, Inc. Class A Shares REVG REV Group Inc REXR Rexford Industrial Realty, Inc. Common Stock REYN Reynolds Consumer Products Inc. Common Stock RFIL RF Industries, Ltd. Common Stock RFL Rafael Holdings, Inc. Class B Common Stock RGA Reinsurance Group of America, Incorporated Common Stock RGEN Repligen Corporation Common Stock RGLD Royal Gold, Inc. Common Stock RGS Regis Corporation Common Stock RH RH Common Stock RHI Robert Half Inc. Common Stock RILY BRC Group Holdings, Inc. Common Stock RIME Algorhythm Holdings, Inc. Common Stock RIO Rio Tinto Plc Common Stock RITM Rithm Capital Corp. Common Stock RITR Reitar Logtech Holdings Limited Ordinary shares RIVN Rivian Automotive, Inc. Class A Common Stock RJET Republic Airways Holdings Inc. Common Stock RKDA Arcadia Biosciences, Inc. Common Stock RKLB Rocket Lab Corporation Common Stock RKT Rocket Companies, Inc. Class A Common Stock RLI RLI Corp. Common Stock (DE) RLMD Relmada Therapeutics, Inc. Common Stock RLX RLX Technology Inc. American Depositary Shares, each representing the right to receive one (1) Class A ordinary share RLYB Rallybio Corporation Common Stock RMCF Rocky Mountain Chocolate Factory, Inc. Common Stock RMCO Royalty Management Holding Corporation Class A Common Stock RMTI Rockwell Medical, Inc. Common Stock RNG RingCentral, Inc. Class A Common Stock RNR RenaissanceRe Holdings Ltd. Common Stock RNW ReNew Energy Global plc Class A Ordinary Shares RNXT RenovoRx, Inc. Common Stock ROIV Roivant Sciences Ltd. Common Shares ROKU Roku, Inc. Class A Common Stock ROLR High Roller Technologies, Inc. Common Stock ROMA Roma Green Finance Limited Class A Ordinary Shares RPGL Republic Power Group Limited Class A Ordinary Shares RPID Rapid Micro Biosystems, Inc. Class A Common Stock RPM RPM International Inc. Common Stock RPRX Royalty Pharma plc Class A Ordinary Shares RPTX Repare Therapeutics Inc RRC Range Resources Corporation Common Stock RRGB Red Robin Gourmet Burgers, Inc. Common Stock RRX Regal Rexnord Corporation Common Stock RS Reliance, Inc. Common Stock RSKD Riskified Ltd. Class A Ordinary Shares RSSS Research Solutions, Inc Common Stock RTO Rentokil Initial plc American Depositary Shares (each representing five (5) Ordinary Shares) RUBI Rubico Inc. Common Stock RVMD Revolution Medicines, Inc. Common Stock RVP Retractable Technologies, Inc. Common Stock RVSN Rail Vision Ltd. Ordinary Share RVYL Ryvyl Inc. Common Stock RWAY Runway Growth Finance Corp. Common Stock RY Royal Bank Of Canada Common Stock RYAAY Ryanair Holdings plc American Depositary Shares RYAN Ryan Specialty Holdings, Inc. Class A Common Stock RYDE Ryde Group Ltd. Class A Ordinary Shares RYET Ruanyun Edai Technology Inc. Ordinary shares RYI Ryerson Holding Corp RYM RYTHM, Inc. Common Stock RYN Rayonier Inc. REIT Common Stock RYOJ rYojbaba Co., Ltd. Common Shares › 米国株の一覧 6 / 100
RARE Ultragenyx Pharmaceutical Inc. Common Stock の財務データ・業績推移
RARE（Ultragenyx Pharmaceutical Inc. Common Stock）が米国証券取引委員会（SEC）へ提出した年次報告書（annual report / Form 10-K）のXBRLを、そのまま年度別に並べた財務データです。掲載範囲はFY2013〜FY2025の13期。金額は原則として提出時の米ドル表示、利益は株式報酬（SBC）を費用控除したGAAPベースです。
直近のFY2025（決算期2025-12-31）は売上高$673.0M、営業利益-$535.0M、純利益-$575.0M、希薄化後EPS$-5.83。
RAREの年次サマリー（SEC提出書類）
損益計算書
項目 FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
売上高
— $2.6M $51.5M $103.7M $271.0M $351.4M $363.3M $434.2M $560.2M $673.0M 営業利益
-$248.0M -$328.9M -$371.4M -$424.2M -$330.1M -$381.7M -$648.9M -$569.2M -$536.0M -$535.0M 税引前利益
-$245.8M -$318.3M -$197.1M -$399.4M -$185.4M -$453.0M -$701.7M -$608.5M -$567.6M -$571.0M 純利益（GAAP）
-$245.9M -$302.1M -$197.6M -$402.7M -$186.6M -$454.0M -$707.4M -$606.6M -$569.2M -$575.0M EBITDA
-$244.6M -$323.1M -$351.8M -$415.6M -$317.9M -$368.5M -$630.7M -$543.2M -$500.4M -$500.0M 純利益率
— -11,567.3% -383.7% -388.3% -68.8% -129.2% -194.7% -139.7% -101.6% -85.4%
貸借対照表
項目 FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
総資産
$540.6M $490.8M $719.6M $1.14B $1.76B $1.52B $1.55B $1.49B $1.50B $1.53B 流動資産
$401.7M $269.6M $522.4M $851.0M $1.30B $856.6M $883.9M $732.2M $817.1M $951.0M 現金及び現金同等物
$161.1M $100.5M $113.4M $433.6M $713.5M $307.6M $132.9M $213.6M $173.7M $421.0M 負債合計
$66.7M $107.3M $110.7M $481.7M $605.2M $599.8M $1.19B $1.22B $1.24B $1.61B 株主資本
$474.0M $383.5M $608.9M $653.8M $1.15B $922.6M $352.5M $275.4M $255.3M -$80.0M
キャッシュフロー計算書
項目 FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
営業キャッシュフロー
— — -$290.6M -$345.4M -$132.2M -$338.7M -$380.5M -$474.8M -$414.2M -$466.0M 設備投資
$10.2M $2.8M $4.1M $24.8M $43.9M $73.1M $116.1M $44.3M $7.5M $6.0M フリーキャッシュフロー
— — -$294.6M -$370.2M -$176.1M -$411.8M -$496.6M -$519.1M -$421.7M -$472.0M
1株当たり・株式数
項目 FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
EPS（基本・GAAP）
— — $-1.73 — $-0.37 — $-10.12 $-8.25 $-6.29 $-5.83 EPS（希薄化後・GAAP）
— — $-1.73 — $-0.37 — $-10.12 $-8.25 $-6.29 $-5.83 1株当たり純資産
$11.49 $8.68 $11.97 $11.30 $17.28 $13.30 $5.02 $3.35 $2.76 $-0.83 希薄化後平均株式数
— — — — — — 69.91M 73.54M 90.54M 98.60M
出典: SEC提出書類（10-K / annual report）。値はXBRLの報告値をそのまま用い、四半期への按分や推測は行っていません。1株当たり指標と株式数は、その後の株式分割をさかのぼって反映し、いまの株価と同じ株数の基準にそろえています（分割前の年度は提出書類の数字と異なります。報告値はAPIの reported に残しています）。
売上高と営業利益の推移で、事業規模と利益率の変化を確認できます。
EPS・キャッシュフロー・株主資本を組み合わせると、会計上の利益と現金創出力の差を見やすくなります。
同じ銘柄の株価チャート もあわせて確認できます。